Skip to main content

GeoVax Labs, Inc. (GOVX) Stock Forecast

Data as of May 8, 2026

Healthcare · Current price $1.62 (-7.95%)

Consensus Target
$4.00
Upside
+8520.7%
Analysts
4
Rating
Buy(2.50)

Price Target Range

Low $4.00High $4.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy0
Hold2
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

GOVX vs Sector & Market

MetricGOVXHealthcare AvgLarge Cap Avg
Analyst Rating2.502.242.41
Analyst Count4818
Target Upside+8520.7%+1139.7%+14.9%
P/E Ratio-0.053.1027.95

Revenue Estimates

PeriodLowAvgHigh#
2026-12-31$3M$3M$3M2
2027-12-31$520M$520M$520M2
2028-12-31$232M$232M$232M2
2029-12-31$287M$287M$287M1

EPS Estimates

PeriodLowAvgHigh#
2026-12-31$-33.09$-22.25$-11.412
2027-12-31$-26.93$-14.13$-1.322
2028-12-31$-0.59$26.75$54.092
2029-12-31$29.75$29.75$29.751

Frequently Asked Questions

What is the analyst consensus for GOVX?

The consensus among 4 analysts covering GeoVax Labs, Inc. (GOVX) is Buy with an average price target of $4.00.

What is the highest price target for GOVX?

The highest analyst price target for GOVX is $4.00.

What is the lowest price target for GOVX?

The lowest analyst price target for GOVX is $4.00.

How many analysts cover GOVX?

4 analysts have issued ratings for GeoVax Labs, Inc. in the past 12 months.

Is GOVX a buy or sell right now?

Based on 4 analyst ratings, GOVX has a consensus rating of Buy (2.50/5) with a +8520.7% upside to the consensus target of $4.00.

What are the earnings estimates for GOVX?

Analysts estimate GOVX will report EPS of $-22.25 for the period ending 2026-12-31, with revenue estimated at $3M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.